ASPCF News and Press, Acerus Pharmaceuticals Corp From 07/28/20

Product En Route to United States and Taiwan Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a speciality pharmaceutical company focused on the commercialization of novel prescription products for men’s health, today announced that production of new batches of NATESTO...

Dr. Chris Sorli, MD, PhD, FACE Joins Acerus’ Executive Leadership Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB: ASPCF) today announced that Dr. Christopher Sorli, MD, PhD, FACE will join the Company as Chief Medical ...

Initially 22 in Size, Dedicated Staff to Target Urologists and Endocrinologists Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a specialty pharmaceutical company focused on the commercialization of novel prescription products for men’s health, today announced the lau...

Acerus Pharmaceuticals Corporation (“ Acerus ”) (TSX:ASP; OTCQB:ASPCF) today announced the voting results from its annual meeting of shareholders held on June 23, 2020 in Toronto, Ontario. The total number of shares represented in person or by proxy at the meeting was 898,135,42...

NATESTO ® now covered as a Preferred Brand by leading national pharmacy benefits manager Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF), a specialty pharmaceutical company focused on the commercialization of novel prescription products in Men’s Health, today ann...

Acerus Pharmaceuticals Corporation (ASPCF) Q1 2020 Earnings Conference Call May 12, 2020 8:30 AM ET Company Participants Bob Motz – Chief Financial Officer Ed Gudaitis – President and Chief Executive Officer Conference Call Participants Presentation Operato...

Acerus Pharmaceuticals ( OTCQB:ASPCF ): Q1 GAAP EPS of -$0.01. More news on: Acerus Pharmaceuticals Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period ended March 31, 2020 (“Q1-2020). Unless otherwise noted, all amounts are in US dollars and are prepared in...

Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) announced that Norma Beauchamp has resigned as a member of the Company's Board of Directors. The Acerus team and the Company’s Board of Directors thank Ms. Beauchamp for he...

Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its first quarter 2020 financial and operating results on Tuesday May 12, 2020 before the market opens. The company will host a conference call on Tuesday, May 12, 2020 at 8:30 a.m. Eastern Time. To access the call li...